Clinical trial
Effects of Eplerenone on Left Ventricular Remodelling Following Heart Attack
NCT00132093 · NHS Greater Glasgow and Clyde, Other · Completed
Key facts
| NCT number | NCT00132093 |
|---|---|
| Title | Effects of Eplerenone on Left Ventricular Remodelling Following Heart Attack |
| Official title | The Effects of Eplerenone on Left Ventricular Remodelling Post-Acute Myocardial Infarction: a Double-Blind Placebo-Controlled Cardiac MR-Based Study |
| Lead sponsor | NHS Greater Glasgow and Clyde, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Myocardial Infarction |
| Intervention type | Drug |
| Interventions | Eplerenone |
| Enrollment | 100 |
| Start date | Apr 1, 2005 |
| First posted | Aug 19, 2005 |
| Last update posted | Apr 10, 2006 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: